<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mena-mig01/PMC5537062/results/search/mena-migration/results.xml">
  <result pre="unknown. This study aimed to investigate the oncogenic potential of" exact="MENA" post="and its capacity to regulate cancer stem cell (CSC)‐like"/>
  <result pre="HCC cells were generated from HCC cell lines. Transwell cell" exact="migration" post="and colony formation assays were employed to evaluate tumorigenicity."/>
  <result pre="formation assays were employed to evaluate tumorigenicity. Ectopic expression of" exact="MENA" post="significantly enhanced cell migration and colony‐forming ability in HCC"/>
  <result pre="to evaluate tumorigenicity. Ectopic expression of MENA significantly enhanced cell" exact="migration" post="and colony‐forming ability in HCC cells. Overexpression of MENA"/>
  <result pre="cell migration and colony‐forming ability in HCC cells. Overexpression of" exact="MENA" post="upregulated several hepatic progenitor/stem cell markers in HCC cells."/>
  <result pre="several hepatic progenitor/stem cell markers in HCC cells. A high" exact="MENA" post="protein level was associated with high mRNA levels of"/>
  <result pre="cell adhesion molecule (EpCAM) in human HCC tissues. Overexpression of" exact="MENA" post="enhanced epithelial‐to‐mesenchymal transition (EMT) markers, extracellular signal‐regulated kinases (ERK)"/>
  <result pre="β‐catenin in HCC cells. This study demonstrated that overexpression of" exact="MENA" post="in HCC cells promoted stem cell markers, EMT markers,"/>
  <result pre="HCC hepatocellular carcinoma HPC hepatic progenitor cell LCSCs liver CSCs" exact="MENA" post="mammalian‐enabled SEM standard error of the mean Liver cancer"/>
  <result pre="CSCs (LCSCs) have been shown to possess significant capacities of" exact="migration" post="and invasion and resistant to radiation and chemotherapy, thus"/>
  <result pre="has the functions such as cell motility and adhesion 23." exact="MENA" post="is undetectable in many normal tissues, but is highly"/>
  <result pre="addition, researches on breast cancer have shown that expression of" exact="MENA" post="is associated with tumor invasion and metastasis 24. In"/>
  <result pre="and metastasis 24. In the studies on hepatocellular carcinoma 25," exact="MENA" post="may be involved in the development and progression of"/>
  <result pre="Our previous study on 81 patients with HCC found that" exact="MENA" post="is overexpressed in 40.74% paraffin‐embedded HCC specimens. Compared to"/>
  <result pre="in MENA‐positive group. Furthermore, multivariate Cox regression analysis shows that" exact="MENA" post="overexpression is a risk factor for DFS (HR: 2.309,"/>
  <result pre="26. Recently, Lin et al. 25 demonstrated that knockdown of" exact="MENA" post="reduced HCC cell migration and invasion in vitro, as"/>
  <result pre="al. 25 demonstrated that knockdown of MENA reduced HCC cell" exact="migration" post="and invasion in vitro, as well as their metastasis"/>
  <result pre="oncogenic potential for MENA. Even though the oncogenic potential of" exact="MENA" post="in HCC cells has been revealed, however, the underlying"/>
  <result pre="revealed, however, the underlying molecular mechanism remains to be investigated." exact="MENA" post="is an EMT‐dependent alternatively spliced gene. The splice isoform"/>
  <result pre="is an EMT‐dependent alternatively spliced gene. The splice isoform of" exact="MENA" post="with the exon 11a is a characteristic for epithelial"/>
  <result pre="found in mesenchymal cells 27. Meanwhile, the splice isoform of" exact="MENA" post="has also been found to be expressed in primary"/>
  <result pre="the detailed mechanism is still unknown, these findings suggest that" exact="MENA" post="gene may play a role in the regulation of"/>
  <result pre="of HCC 34. Based on these observations, we hypothesized that" exact="MENA" post="may play a role in the regulations of CSC"/>
  <result pre="of this study was to investigate the oncogenic potential of" exact="MENA" post="and its capacity to regulate CSC and EMT phenotypes"/>
  <result pre="USA), vimentin (Cat.#sc‐6260, Santa Cruz), β‐catenin (Cat.# 9562, Cell signaling)," exact="MENA" post="(Cat.# 2075, Cell signaling), and α‐tubulin (Cat.#ab15246, Abcam, Cambridge,"/>
  <result pre="USA) were all used in this study. In vitro cell" exact="migration" post="assay In vitro cell migration assays were performed in"/>
  <result pre="this study. In vitro cell migration assay In vitro cell" exact="migration" post="assays were performed in Transwell chambers (8 μm pore"/>
  <result pre="PCR with specific primer pair for the promoter region of" exact="MENA" post="gene (sense 5′‐TATATGCCCCTCCTCAAC‐3′, antisense 5′‐GTTCCTC GCCCGTGGTTG‐3′). Statistical analysis Statistical"/>
  <result pre="HCC cell lines Our previous work showed that overexpression of" exact="MENA" post="is associated with poor cellular differentiation, advanced tumor stage,"/>
  <result pre="DFS in HCC. To further investigate the oncogenic potential of" exact="MENA" post="in vitro, we attempted to generate stable MENA‐overexpressing HCC"/>
  <result pre="vitro, we attempted to generate stable MENA‐overexpressing HCC cell lines." exact="MENA" post="protein levels were screened in six HCC cell lines."/>
  <result pre="1A, Huh‐7, PLC‐8024, MHCC‐97L, and MHCC‐97H cells were positive for" exact="MENA" post="protein, whereas SMMC‐7721 and QGY‐7703 cells were nearly negative"/>
  <result pre="were chosen to establish the stable MENA‐overexpressing HCC cells (SMMC‐7721" exact="MENA" post="and QGY‐7703 MENA). The overexpression of MENA protein levels"/>
  <result pre="HCC cells (SMMC‐7721 MENA and QGY‐7703 MENA). The overexpression of" exact="MENA" post="protein levels was confirmed by western blot in SMMC‐7721‐MENA"/>
  <result pre="(Fig. 1C). Figure 1 Generating MENA‐overexpressing HCC cell lines. (A)" exact="MENA" post="protein levels of six HCC cell lines were determined"/>
  <result pre="to generate the stable MENA‐overexpressing HCC cells. The overexpression of" exact="MENA" post="proteins was confirmed by western blot. Overexpression of MENA"/>
  <result pre="of MENA proteins was confirmed by western blot. Overexpression of" exact="MENA" post="enhanced tumorigenicity of HCC cells The proliferative and metastatic"/>
  <result pre="more colonies than the control cells. In addition, transwell cell" exact="migration" post="assay showed that QGY‐7703‐MENA cells had a significantly higher"/>
  <result pre="migration assay showed that QGY‐7703‐MENA cells had a significantly higher" exact="migration" post="ability as compared with the vector control cells (Fig."/>
  <result pre="2C, P &amp;lt; 0.01). These data suggested that overexpression of" exact="MENA" post="enhanced tumorigenicity in HCC cell lines. Figure 2 Overexpression"/>
  <result pre="enhanced tumorigenicity in HCC cell lines. Figure 2 Overexpression of" exact="MENA" post="enhanced tumorigenicity in HCC cells. Colony formation assay (A),"/>
  <result pre="(A), soft agar colony formation assay (B), and transwell cell" exact="migration" post="assay (C) were employed to determine the tumorigenicity. The"/>
  <result pre="control cells. **P &amp;lt; 0.01; ***P &amp;lt; 0.001. Overexpression of" exact="MENA" post="upregulated hepatic progenitor/stem cell markers and Wnt/β‐catenin signaling markers"/>
  <result pre="a characteristic of CSCs, next we investigated whether overexpression of" exact="MENA" post="impacted on CSC‐like characteristics of HCC cells. As shown"/>
  <result pre="of HCC cells. As shown in Fig. 3, overexpression of" exact="MENA" post="dramatically upregulated the mRNA levels of hepatic progenitor cell"/>
  <result pre="and Sox2, and Wnt signaling marker β‐catenin in both stable" exact="MENA" post="HCC cell lines as compared with their vector control"/>
  <result pre="not change after overexpression of MENA. Figure 3 Overexpression of" exact="MENA" post="upregulated hepatic progenitor/stem cell markers and Wnt/β‐catenin signaling markers"/>
  <result pre="cells were compared with their vector control counterparts, respectively. (C)" exact="MENA" post="expression levels were determined by RT‐PCR using RNA extract"/>
  <result pre="from CD133+/CD133−Huh7 and PLC‐8024 cells, respectively. Real‐time‐PCR analysis found that" exact="MENA" post="expression was only detected in total RNA extract of"/>
  <result pre="only LCSCs express MENA. Taken together, these data suggested that" exact="MENA" post="may play a role in CSC regulation of HCC"/>
  <result pre="play a role in CSC regulation of HCC cells. High" exact="MENA" post="protein was associated with high mRNA levels of MENA,"/>
  <result pre="and EpCAM in human HCC tissues To further confirm whether" exact="MENA" post="plays a role in CSC regulation of HCC cells,"/>
  <result pre="groups (n = 33) according to their expression level of" exact="MENA" post="protein as previously described 26. The mRNA levels of"/>
  <result pre="CK19 and EpCAM were compared between two groups. As expected," exact="MENA" post="mRNA level was significantly higher in MENA‐High group than"/>
  <result pre="with MENA‐Low group. These data indicated that high expression of" exact="MENA" post="was associated with elevated CSC markers in HCC cells."/>
  <result pre="with elevated CSC markers in HCC cells. Figure 4 High" exact="MENA" post="protein was associated with high mRNA levels of MENA,"/>
  <result pre="groups (n = 33) according to their expression level of" exact="MENA" post="protein. The mRNA levels of MENA (A), CSC marker"/>
  <result pre="their expression level of MENA protein. The mRNA levels of" exact="MENA" post="(A), CSC marker CD133 (B), and HPC markers CK19"/>
  <result pre="RT‐PCR and compared between two groups (Student's t‐test). Overexpression of" exact="MENA" post="promoted EMT, ERK phosphorylation, and β‐catenin protein level Finally,"/>
  <result pre="E‐cadherin and vimentin. As shown in Fig. 5A, overexpression of" exact="MENA" post="simultaneously downregulated E‐cadherin and upregulated vimentin in QGY‐7703‐MENA cells,"/>
  <result pre="downregulated E‐cadherin and upregulated vimentin in QGY‐7703‐MENA cells, suggesting that" exact="MENA" post="promoted EMT. The data also showed that overexpression of"/>
  <result pre="MENA promoted EMT. The data also showed that overexpression of" exact="MENA" post="elevated protein level of p‐ERK (Fig. 5A), suggesting that"/>
  <result pre="protein level of p‐ERK (Fig. 5A), suggesting that overexpression of" exact="MENA" post="activates ERK signaling pathway. Figure 5 Overexpression of MENA"/>
  <result pre="of MENA activates ERK signaling pathway. Figure 5 Overexpression of" exact="MENA" post="promoted EMT, ERK phosphorylation and β‐catenin protein level. (A)"/>
  <result pre="analyze the β‐catenin protein binding to the promoter region of" exact="MENA" post="gene in HCC cells. Mouse IgG was used as"/>
  <result pre="showed that β‐catenin directly bound with the promoter region of" exact="MENA" post="gene. Previous study has demonstrated that MENA is a"/>
  <result pre="promoter region of MENA gene. Previous study has demonstrated that" exact="MENA" post="is a transcriptional target of Wnt/β‐catenin pathway 36. To"/>
  <result pre="pathway 36. To address whether β‐catenin pathway is associated with" exact="MENA" post="in HCC cells, we determined β‐catenin protein level in"/>
  <result pre="confirmed that β‐catenin directly bound with the promoter region of" exact="MENA" post="gene (Fig. 5B), demonstrating that MENA is a transcriptional"/>
  <result pre="the promoter region of MENA gene (Fig. 5B), demonstrating that" exact="MENA" post="is a transcriptional target of β‐catenin in HCC cells."/>
  <result pre="Discussion In this study, we investigated the oncogenic potential of" exact="MENA" post="and its underlying mechanism in HCC cells. The data"/>
  <result pre="mechanism in HCC cells. The data showed that overexpression of" exact="MENA" post="significantly enhanced colony‐forming and migration abilities in HCC cells."/>
  <result pre="data showed that overexpression of MENA significantly enhanced colony‐forming and" exact="migration" post="abilities in HCC cells. Overexpression of MENA in HCC"/>
  <result pre="enhanced colony‐forming and migration abilities in HCC cells. Overexpression of" exact="MENA" post="in HCC cell lines also upregulated the HPC markers"/>
  <result pre="and the stem cell markers (Oct4, Sox2). In addition, high" exact="MENA" post="protein level was associated with elevated mRNA levels of"/>
  <result pre="and EpCAM in human HCC tissue samples. Furthermore, overexpression of" exact="MENA" post="promoted EMT and ERK phosphorylation and level of β‐catenin"/>
  <result pre="level of β‐catenin in HCC cells. These data suggested that" exact="MENA" post="has the ability to enhance tumorigenicity and the expressions"/>
  <result pre="signaling pathways. Our previous work showed that high expression of" exact="MENA" post="in human HCC tissues is associated with poor cellular"/>
  <result pre="tissues is associated with poor cellular differentiation 26, implying that" exact="MENA" post="may play a role in the dedifferentiation of HCC."/>
  <result pre="The current study further demonstrated that HCC samples with elevated" exact="MENA" post="protein displayed high levels of LCSC markers CD133, CK19,"/>
  <result pre="differentiation, chemoresistance, and tumorigenicity in mice. Our data showed that" exact="MENA" post="expression was detected only in CD133+ HCC cell lines"/>
  <result pre="association between CD133 and MENA. The phenomenon that overexpression of" exact="MENA" post="in HCC cell lines resulted in unchanged level of"/>
  <result pre="in unchanged level of CSC marker CD133 may indicate that" exact="MENA" post="may be a downstream protein of CD133 so that"/>
  <result pre="be a downstream protein of CD133 so that overexpression of" exact="MENA" post="had no effect on CD133 level. Further study is"/>
  <result pre="study is required to elucidate the relationship between CD133 and" exact="MENA" post="in CSCs. These results also indicated that MENA may"/>
  <result pre="CD133 and MENA in CSCs. These results also indicated that" exact="MENA" post="may play a role in the regulation of CSC"/>
  <result pre="in HCC cells. It is worth to further investigate whether" exact="MENA" post="regulates CD133+ LCSCs by establishing a MENA‐overexpressing CD133+ HCC"/>
  <result pre="of HCC. Our previous finding demonstrated that high expression of" exact="MENA" post="in human HCC tissues is associated with advanced tumor"/>
  <result pre="of both CSC and EMT markers and enhanced capacities of" exact="migration" post="and colony formation, suggesting an oncogenic potential of MENA"/>
  <result pre="of migration and colony formation, suggesting an oncogenic potential of" exact="MENA" post="in HCC. In addition, our observations further supported the"/>
  <result pre="To our best knowledge, our data report the effects of" exact="MENA" post="on expressions of CSC and EMT markers in HCC"/>
  <result pre="MENA‐overexpressing HCC cells. In addition, the ChIP data showed that" exact="MENA" post="is a transcriptional target of β‐catenin in HCC cells."/>
  <result pre="target of β‐catenin in HCC cells. These findings suggested that" exact="MENA" post="may regulate CSC features and EMT in HCC through"/>
  <result pre="current study. First, although our results found that overexpression of" exact="MENA" post="elevated the levels of several LCSC biomarkers in HCC"/>
  <result pre="we did not examine the effect of stable knockdown of" exact="MENA" post="on the levels of LCSC biomarkers in high MENA‐expressing"/>
  <result pre="MENA‐expressing cells. We also did not evaluate the effects of" exact="MENA" post="overexpression on the other key features of CSC, such"/>
  <result pre="in this study, and the immunofluorescence data of colocalization of" exact="MENA" post="and stem cell markers (CK19 and CD133) in human"/>
  <result pre="and CD133) in human HCC tissues are important to validate" exact="MENA" post="as a stemness marker. Furthermore, in the following study,"/>
  <result pre="following study. In summary, this study demonstrated that overexpression of" exact="MENA" post="enhanced expression of CSC markers and EMT markers, as"/>
  <result pre="cells, which provide partial mechanisms for the oncogenic role of" exact="MENA" post="in the metastasis and recurrence of HCC. Our findings"/>
  <result pre="YangXM, LiJ, ZhangYL, QinW and ZhangZG (2014) Microfilament regulatory protein" exact="MENA" post="increases activity of RhoA and promotes metastasis of hepatocellular"/>
  <result pre="36NajafovA, SekerT, EvenI, HoxhajG, SelviO, OzelDE, KomanA and Birgül‐İyisonN (2012)" exact="MENA" post="is a transcriptional target of the Wnt/beta‐catenin pathway. PLoS"/>
 </snippets>
</snippetsTree>
